Skip to main content

Table 5 Multivariable logistic regression analyses of factors associated with reasons for no-intent to receivea human papillomavirus vaccine (HPV) series among unvaccinated female adolescents aged 13–17 years, National Immunization Survey - Teen, 2008–2012 (n = 12,274b)

From: Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012

 

Adjusted odds ratio (95% confidence interval)c

Factors

Safety and Effectiveness Concernsd

Systemic Barrierse

Vaccine Misinformationf

Lack of Knowledge about the Vaccineg

Socio-cultural reasonsh

Age, years

 13

1.00

1.00

1.00

1.00

1.00

 14

0.99 (0.78–1.27)

1.15 (0.86–1.52)

0.90 (0.74–1.10)

1.27 (0.95–1.70)

0.78 (0.54–1.13)

 15

0.94 (0.75–1.19)

0.93 (0.69–1.24)

0.88 (0.72–1.08)

1.37 (1.05–1.80)

1.57 (1.09–2.26)

 16

1.01 (0.79–1.30)

0.84 (0.63–1.13)

0.76 (0.61–0.93)

1.52 (1.13–2.05)

1.29 (0.82–2.01)

 17

1.00 (0.78–1.29)

1.01 (0.76–1.36)

0.69 (0.56–0.84)

1.10 (0.83–1.47)

1.52 (1.01–2.30)

Race/ethnicity

 White, non–Hispanic

1.00

1.00

1.00

1.00

1.00

 Black, non–Hispanic

0.75 (0.57–0.98)

1.05 (0.78–1.41)

0.98 (0.80–1.20)

1.42 (1.09–1.86)

1.63 (1.15–2.32)

 Hispanic

0.80 (0.59–1.10)

1.02 (0.75–1.38)

0.93 (0.73–1.19)

1.58 (1.14–2.17)

1.14 (0.72–1.81)

 Otheri

0.70 (0.52–0.94)

1.39 (1.00–1.94)

0.80 (0.62–1.02)

1.45 (1.04–2.00)

0.88 (0.54–1.44)

 Number of people in the household, per person over two

0.86 (0.81–0.91)

0.97 (0.91–1.04)

1.08 (1.03–1.14)

1.00 (0.92–1.09)

1.09 (0.98–1.22)

Annual household income, US $

 ≤35,000

1.00

1.00

1.00

1.00

1.00

 35,001–75,000

1.13 (0.88–1.47)

0.64 (0.49–0.83)

1.03 (0.84–1.27)

1.20 (0.91–1.59)

1.62 (1.04–2.55)

 >75,000

1.10 (0.84–1.46)

0.62 (0.46–0.83)

1.04 (0.83–1.31)

0.95 (0.70–1.30)

1.91 (1.14–3.19)

Mother’s education

     

 Less than high school

1.00

1.00

1.00

1.00

1.00

 High school

1.52 (1.02–2.28)

0.77 (0.52–1.13)

1.12 (0.82–1.53)

0.95 (0.66–1.38)

1.18 (0.58–2.43)

 Some college

1.79 (1.20–2.68)

0.76 (0.53–1.10)

1.24 (0.91–1.68)

0.76 (0.53–1.08)

1.32 (0.67–2.59)

 College graduate

1.84 (1.21–2.81)

0.82 (0.56–1.20)

1.51 (1.10–2.06)

0.48 (0.34–0.69)

1.55 (0.74–3.24)

Mother’s marital status

 Otherj

1.00

1.00

1.00

1.00

1.00

 Married

1.22 (0.98–1.52)

1.18 (0.92–1.52)

1.09 (0.88–1.34)

0.88 (0.63–1.22)

0.71 (0.51–0.98)

Mother’s age, years

 ≤34

1.00

1.00

1.00

1.00

1.00

 35–44

0.99 (0.71–1.36)

0.91 (0.63–1.33)

0.85 (0.64–1.13)

1.56 (1.06–2.31)

0.55 (0.31–0.98)

 ≥45

0.86 (0.62–1.21)

0.98 (0.67–1.43)

0.92 (0.69–1.23)

1.48 (1.00–2.22)

0.56 (0.31–1.01)

Health insurance statusk

 Private

1.00

1.00

1.00

1.00

1.00

 SCHIP or Medicaid

1.21 (0.93–1.56)

0.97 (0.73–1.30)

0.83 (0.66–1.02)

0.73 (0.54–1.00)

1.34 (0.86–2.07)

 IHS or Military

1.20 (0.71–2.06)

0.76 (0.35–1.70)

0.75 (0.47–1.19)

0.83 (0.42–1.64)

1.63 (0.76–3.49)

 Other

0.88 (0.63–1.22)

0.99 (0.66–1.47)

0.87 (0.64–1.19)

1.32 (0.77–2.27)

1.31 (0.74–2.34)

 Uninsured

0.98 (0.69–1.38)

1.06 (0.73–1.52)

0.86 (0.65–1.15)

1.30 (0.91–1.88)

0.69 (0.38–1.25)

Healthcare provider recommended HPV vaccine

 Yes

1.00

1.00

1.00

1.00

1.00

 No

0.42 (0.36–0.49)

6.84 (5.25–8.91)

1.18 (1.02–1.35)

0.86 (0.69–1.07)

0.49 (0.38–0.63)

Survey Year

 2008

1.00

1.00

1.00

1.00

1.00

 2009

1.45 (1.09–1.93)

0.93 (0.70–1.24)

0.80 (0.64–0.99)

0.96 (0.71–1.30)

2.07 (1.39–3.07)

 2010

2.83 (2.16–3.70)

0.93 (0.70–1.24)

0.85 (0.69–1.04)

0.63 (0.47–0.85)

0.95 (0.60–1.52)

 2011

2.18 (1.68–2.83)

0.87 (0.65–1.16)

1.02 (0.83–1.25)

0.66 (0.50–0.87)

1.14 (0.75–1.72)

 2012

1.45 (1.09–1.93)

1.57 (1.17–2.09)

0.67 (0.53–0.84)

0.64 (0.47–0.87)

1.47 (0.95–2.27)

  1. a“no-intent” to initiate the HPV vaccine series in the next 12 months; bSample size with complete data on all the covariates in the logistic regression models
  2. cLogistic regression models include all the variables listed; dSafety and effectiveness concerns category included the cited reasons of safety and side effects, new vaccine, need more information, and effectiveness concerns; e Systemic barriers includes: health care provider not recommended, cost, vaccine not available, no doctor/obstetrician/gynecologist/doctor visit scheduled, and not a school requirement; fVaccine misinformation includes: not needed/not necessary, adolescent not sexually active, not appropriate age, and concern of increased sexual activity; g lack of knowledge about the vaccine included the response lack of knowledge; and h Sociocultural reasons included: family/parental decision, do not believe in immunizations, and against religion/orthodox
  3. iIncludes non-Hispanic other racial/ethnic groups and biracial; jNever married/widowed/divorced/separated; kSCHIP = State Children’s Health Insurance Program; IHS = Indian Health Service